These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 28618015

  • 21. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.
    Greisen SR, Møller HJ, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Junker P, Østergaard M, Hvid M, Deleuran B.
    Clin Exp Rheumatol; 2015; 33(4):498-502. PubMed ID: 25962601
    [Abstract] [Full Text] [Related]

  • 22. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.
    Bossen L, Vesterhus M, Hov JR, Färkkilä M, Rosenberg WM, Møller HJ, Boberg KM, Karlsen TH, Grønbæk H.
    Clin Transl Gastroenterol; 2021 Mar 01; 12(3):e00315. PubMed ID: 33646203
    [Abstract] [Full Text] [Related]

  • 23. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A, Støy S, Thomsen KL, Hvas CL, Agnholt J, Dahlerup JF, Møller HJ, Grønbaek H.
    Scand J Immunol; 2014 Dec 01; 80(6):417-23. PubMed ID: 25346048
    [Abstract] [Full Text] [Related]

  • 24. Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
    Grønbaek H, Møller HJ, Saliba F, Zeuzem S, Albillos A, Ariza X, Graupera I, Solà E, Amoros A, Pavesi M, Bossen L, Jalan R, Gines P, Arroyo V.
    J Gastroenterol Hepatol; 2021 Jan 01; 36(1):240-248. PubMed ID: 32478437
    [Abstract] [Full Text] [Related]

  • 25. Macrophage Activation Markers Predict Liver-Related Complications in Primary Biliary Cholangitis.
    Fujinaga Y, Namisaki T, Tsuji Y, Suzuki J, Murata K, Takeda S, Takaya H, Inoue T, Noguchi R, Fujimoto Y, Enomoto M, Nishimura N, Kitagawa K, Kaji K, Kawaratani H, Akahane T, Mitoro A, Yoshiji H.
    Int J Mol Sci; 2022 Aug 29; 23(17):. PubMed ID: 36077228
    [Abstract] [Full Text] [Related]

  • 26. Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis.
    Grønbaek H, Kreutzfeldt M, Kazankov K, Jessen N, Sandahl T, Hamilton-Dutoit S, Vilstrup H, J Møller H.
    Aliment Pharmacol Ther; 2016 Nov 29; 44(10):1062-1070. PubMed ID: 27679428
    [Abstract] [Full Text] [Related]

  • 27. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
    Grønbaek H, Sandahl TD, Mortensen C, Vilstrup H, Møller HJ, Møller S.
    Aliment Pharmacol Ther; 2012 Jul 29; 36(2):173-80. PubMed ID: 22591184
    [Abstract] [Full Text] [Related]

  • 28. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure.
    Li TP, Guan SH, Wang Q, Chen LW, Yang K, Zhang H.
    World J Gastroenterol; 2019 Oct 07; 25(37):5667-5675. PubMed ID: 31602166
    [Abstract] [Full Text] [Related]

  • 29. Expression of soluble sCD163 in serum of psoriatic patients is modulated by Goeckerman therapy.
    Kondelkova K, Krejsek J, Borska L, Fiala Z, Hamakova K, Andrys C.
    Allergol Immunopathol (Madr); 2013 Oct 07; 41(3):158-62. PubMed ID: 22765877
    [Abstract] [Full Text] [Related]

  • 30. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL, Zhang YL, Shu XM, Yang HB, Zhang L, Chen F, Lu X, Wang GC.
    J Rheumatol; 2015 Jun 07; 42(6):979-87. PubMed ID: 25877505
    [Abstract] [Full Text] [Related]

  • 31. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
    Tornai T, Vitalis Z, Sipeki N, Dinya T, Tornai D, Antal-Szalmas P, Karanyi Z, Tornai I, Papp M.
    Liver Int; 2016 Nov 07; 36(11):1628-1638. PubMed ID: 27031405
    [Abstract] [Full Text] [Related]

  • 32. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure.
    Hiraoka A, Horiike N, Akbar SM, Michitaka K, Matsuyama T, Onji M.
    J Gastroenterol; 2005 Jan 07; 40(1):52-6. PubMed ID: 15692789
    [Abstract] [Full Text] [Related]

  • 33. Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease.
    Kazankov K, Alisi A, Møller HJ, De Vito R, Rittig S, Mahler B, Nobili V, Grønbæk H.
    J Pediatr Gastroenterol Nutr; 2018 Nov 07; 67(5):635-642. PubMed ID: 30074574
    [Abstract] [Full Text] [Related]

  • 34. Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.
    Rødgaard-Hansen S, St George A, Kazankov K, Bauman A, George J, Grønbæk H, Jon Møller H.
    Scand J Clin Lab Invest; 2017 Nov 07; 77(7):498-504. PubMed ID: 28715286
    [Abstract] [Full Text] [Related]

  • 35. High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study.
    Björklund J, Laursen TL, Sandahl TD, Møller HJ, Vilstrup H, Ott P, Grønbæk H.
    Orphanet J Rare Dis; 2018 Sep 21; 13(1):169. PubMed ID: 30241550
    [Abstract] [Full Text] [Related]

  • 36. Increased concentrations of the soluble mannose receptor in serum from patients with pneumococcal bacteraemia, and prediction of survival.
    Rødgaard-Hansen S, Rafique A, Weis N, Wejse C, Nielsen H, Pedersen SS, Møller HJ, Kronborg G.
    Infect Dis (Lond); 2015 Apr 21; 47(4):203-8. PubMed ID: 25650730
    [Abstract] [Full Text] [Related]

  • 37. Association of serum macrophage-mannose receptor CD206 with mortality in idiopathic pulmonary fibrosis.
    Zou R, Gui X, Zhang J, Tian Y, Liu X, Tian M, Chen T, Wu H, Chen J, Dai J, Cai H.
    Int Immunopharmacol; 2020 Sep 21; 86():106732. PubMed ID: 32622200
    [Abstract] [Full Text] [Related]

  • 38. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
    Baeten D, Møller HJ, Delanghe J, Veys EM, Moestrup SK, De Keyser F.
    Arthritis Rheum; 2004 May 21; 50(5):1611-23. PubMed ID: 15146432
    [Abstract] [Full Text] [Related]

  • 39. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
    Ding D, Yao Y, Yang C, Zhang S.
    Cancer Biomark; 2018 Feb 14; 21(3):689-700. PubMed ID: 29226859
    [Abstract] [Full Text] [Related]

  • 40. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients.
    Tanimura H, Mizuno K, Okamoto H.
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul 22; 32(2):99-105. PubMed ID: 26278688
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.